Comparative 12 month study of menstrually-signalled use of a combined contraceptive pill versus a combined contraceptive vaginal ring
Comparative 12 month study of menstrually-signalled use of an ethinyl oestradiol and levonorgestrel low-dose pill and a low-dose contraceptive vaginal ring containing ethinyl oestradiol and etonogestrel to assess the number of bleeding spotting days
Family Planning NSW
140 participants
Mar 7, 2009
Interventional
Conditions
Summary
Women requiring hormonal contraception who have consented to enter the study will complete a menstrual attitude questionnaire and undergo physical and gynaecological examination and routine haematological and biochemical tests before being randomly assigned to continuous ring or pill use. Women will maintain menstrual diaries for the 12 month study duration. If a bleeding/spotting episode excedes 4 days they will stop their method for 4 days and restart on the fifth day. Women will be contacted monthly to ensure compliance and will be seen at 2 months, 6 months and 12 months from randomisation for follow up At each visit the women will complete an acceptability questionnaire and a menstrual attitudes questionnaire at the final visit.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Use of a low dose oral contraceptive pill containing ethinyl oestradiol 20mcg and levonorgestrel 100mcg once daily for a total of 12 months
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12609000391279